Plasma ranitidine concentrations after intravenous administration in normal volunteers and haemodialysis patients
Open Access
- 1 January 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 59 (687), 25-27
- https://doi.org/10.1136/pgmj.59.687.25
Abstract
Summary: A comparison was made of the plasma concentrations of ranitidine base in 12 normal volunteers after the administration of 100 mg intravenously and in 6 patients with terminal renal failure after 40 mg intravenously off and then during haemodialysis. The plasma ranitidine concentrations were determined by radioimmunoassay. The results suggest that reduced elimination of the drug occurs in patients with severe renal failure and that there is significant removal of the drug during haemodialysis. It is suggested that dosage reduction is advisable in patients with severe renal failure and a suitable schedule for such patients is described.This publication has 4 references indexed in Scilit:
- Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The development of a radioimmunoassay for ranitidine in biological fluidsLife Sciences, 1981
- PHARMACOLOGICALLY EFFECTIVE PLASMA CONCENTRATIONS OF RANITIDINEThe Lancet, 1979
- INHIBITION OF PENTAGASTRIN-STIMULATED AND NOCTURNAL GASTRIC SECRETION BY RANITIDINEThe Lancet, 1979